Skip to main content

Research Repository

Advanced Search

The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies

Prakash, Samay; Carter, Wayne G.

The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies Thumbnail


Authors

Samay Prakash



Abstract

Currently, there are no pharmacological treatments able to reverse nigral degeneration in Parkinson’s disease (PD), hence the unmet need for the provision of neuroprotective agents. Cannabis-derived phytocannabinoids (CDCs) and resveratrol (RSV) may be useful neuroprotective agents for PD due to their anti-oxidative and anti-inflammatory properties. To evaluate this, we undertook a systematic review of the scientific literature to assess the neuroprotective effects of CDCs and RSV treatments in pre-clinical in vivo animal models of PD. The literature databases MEDLINE, EMBASE, PsychINFO, PubMed, and Web of Science core collection were systematically searched to cover relevant studies. A total of 1034 publications were analyzed, of which 18 met the eligibility criteria for this review. Collectively, the majority of PD rodent studies demonstrated that treatment with CDCs or RSV produced a significant improvement in motor function and mitigated the loss of dopaminergic neurons. Biochemical analysis of rodent brain tissue suggested that neuroprotection was mediated by anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms. This review highlights the neuroprotective potential of CDCs and RSV for in vivo models of PD and therefore suggests their potential translation to human clinical trials to either ameliorate PD progression and/or be implemented as a prophylactic means to reduce the risk of development of PD.

Citation

Prakash, S., & Carter, W. G. (2021). The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Literature Review of Pre-Clinical Studies. Brain Sciences, 11(12), Article 1573. https://doi.org/10.3390/BRAINSCI11121573

Journal Article Type Article
Acceptance Date Nov 24, 2021
Online Publication Date Nov 28, 2021
Publication Date Dec 1, 2021
Deposit Date Dec 15, 2021
Publicly Available Date Dec 15, 2021
Journal Brain Sciences
Electronic ISSN 2076-3425
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 11
Issue 12
Article Number 1573
DOI https://doi.org/10.3390/BRAINSCI11121573
Keywords General Neuroscience
Public URL https://nottingham-repository.worktribe.com/output/7018546
Publisher URL https://www.mdpi.com/2076-3425/11/12/1573

Files





You might also like



Downloadable Citations